← Back to signals
LLY
STRONG BUYEli Lilly and Company
Health Care
0.46
PEGY ratio
Rank #183
Why This Matters
This stock appears significantly undervalued relative to its growth and dividend yield. Strong projected growth of 83.7% annually over 5 years. Pays a 0.7% dividend yield.
LLY is trading at 38.5x earnings against 83.7% growth + 0.7% yield, giving a PEGY of 0.46. The math suggests the stock is significantly undervalued relative to its growth and income profile.
~ Growth estimate uses historical CAGR (forward estimates unavailable)
- • Growth rate derived from historical CAGR — limited analyst coverage.
Scan date: 2026-04-24
Valuation
38.5x
P/E Ratio
Growth
83.7%
5yr EPS
Income
0.7%
Div Yield
PEGY Components
PEGY Score0.46
Denominator84.4%
EPS (TTM)$22.98
Market Data
Price$883.96
ExchangeNYSE
S&P 500
What Changed
PEGY Score
0.48→0.46(-0.03)
Rank
#133→#183(50 positions)
vs 7 days ago
Portfolio Context
Founder does not hold this stock.
Not in your portfolio.
Sector: Health Care
PEGY History — 90 days
Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only